Clinical Trials in New York State

Showing 821-840 of 17,167 trials

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

NCT05789485

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will also look at the way the body responds to exercise and whether there are differences in treatment. This will include looking at the highest treatment dose participants receive, how many people stop, delay, or reduce the treatment, and whether additional medication is needed to treat side effects of therapy.

Gastrointestinal Cancer

Memorial Sloan Kettering Cancer Center216 participantsStarted Apr 2023

Hartford, Connecticut, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +5 more locations

RECRUITINGNA98 miles

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

NCT00539162

The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.

Ovarian Cancer

M.D. Anderson Cancer Center8,000 participantsStarted Jul 2001

Miami, Florida, United States • Des Moines, Iowa, United States • Morristown, New Jersey, United States +8 more locations

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Find Trials by Condition in New York State

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Strength or Power Training for Patellofemoral Pain

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

Natural History Study of Patients With Canavan Disease (CANinform Study)

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial